1. Introduction {#sec1-nanomaterials-06-00225}
===============

Since the 21st century, nanotechnology has expanded its applicability to various industrial fields including electronics \[[@B1-nanomaterials-06-00225]\], chemical processes \[[@B2-nanomaterials-06-00225]\], medicines \[[@B3-nanomaterials-06-00225]\], and other bio-related fields \[[@B4-nanomaterials-06-00225]\]. Among various nanoparticles (NPs), titanium dioxide (TiO~2~) has attracted tremendous interest as it has attractive physicochemical properties such as semiconducting characteristics \[[@B5-nanomaterials-06-00225]\], photocatalytic effects \[[@B6-nanomaterials-06-00225]\], a high refractive index \[[@B7-nanomaterials-06-00225]\], etc. Indeed, human beings are increasingly being exposed to TiO~2~ NPs due to their extensive applications as food whitening additives \[[@B8-nanomaterials-06-00225],[@B9-nanomaterials-06-00225]\] or sunscreen agents \[[@B10-nanomaterials-06-00225]\]. Diverse particle sizes and unexpected semiconducting properties of TiO~2~ NPs have led to increasing arguments regarding their toxicity. In the early stages of NP toxicity studies, the cytotoxicity of TiO~2~ NPs was studied in terms of both their high specific surface area and semiconducting properties. Donaldson et al. reported that small TiO~2~ particles (\~20 nm) showed more plasmid breakage than larger TiO~2~ (\~500 nm), when they were incubated with plasmid DNA \[[@B11-nanomaterials-06-00225]\]. They also suggested that the surface characteristics of TiO~2~ NPs were crucial to generate free radicals, which mediates DNA destruction. It was also well demonstrated that the semiconducting properties of TiO~2~ NPs could affect cytotoxicity. Uchino et al. reported that Chinese hamster ovary (CHO) cells incubated with Aeroxide^®^ P25 (20 nm sized TiO~2~ NPs produced by Evonik Industries) showed significantly reduced viability after ultraviolet ray irradiation \[[@B12-nanomaterials-06-00225]\]. Zhang et al. also reported that the cell viability of human colon carcinoma LS147T cells significantly decreased to 20% by simultaneous ultraviolet (UV) irradiation and TiO~2~ NP treatment, while only NP-treated cells exhibited more than 90% of their original viability \[[@B13-nanomaterials-06-00225]\].

Despite several studies on the potential cytotoxicity of TiO~2~ NPs, in vivo studies revealed their low oral toxicity. An in vivo study showed that orally administered TiO~2~ NPs (5 mg/kg body) did not induce significant translocation of TiO~2~ into rat organs, suggesting their potential excretion through the feces \[[@B14-nanomaterials-06-00225]\]. Warheit et al. reported that acute oral toxicity of TiO~2~ NPs was very low and even skin irritation and pulmonary toxicity were not significant \[[@B15-nanomaterials-06-00225]\]. Warheit et al. also studied acute and subacute oral toxicity of several types of pigment grade TiO~2~ NPs, showing no remarkable oral toxicity caused in rats \[[@B16-nanomaterials-06-00225]\].

In order to predict the potential in vivo toxicity of TiO~2~ NPs, it should be primarily understood how NPs behave in biomatrices, which contain a variety of chemical species spanning from small molecules and electrolytes to macromolecules such as proteins. Several studies have described that NPs actively interact with various molecules, leading to modification of their colloidal properties such as dispersibility and agglomeration \[[@B17-nanomaterials-06-00225],[@B18-nanomaterials-06-00225],[@B19-nanomaterials-06-00225]\]; their surface chemistry can be also modified in the presence of biomolecules \[[@B20-nanomaterials-06-00225],[@B21-nanomaterials-06-00225]\]. Once NPs are exposed to biological media, they can form protein corona, and this NP-protein complexation can determine their biological fate such as cellular recognition \[[@B22-nanomaterials-06-00225]\]. Another important factor in understanding the in vivo behaviors and toxicity potential of orally administered NPs is the possibility of NP transport across the gastrointestinal barriers. In vitro studies on human intestinal cells showed a low potential of TiO~2~ NPs to be transported across the intestinal epithelium \[[@B23-nanomaterials-06-00225],[@B24-nanomaterials-06-00225]\]. However, contradicting results have been also reported, showing that TiO~2~ NPs could be internalized into cells and transported across the intestinal cell monolayers \[[@B25-nanomaterials-06-00225],[@B26-nanomaterials-06-00225]\]. Meanwhile, several in vivo experiments demonstrated that TiO~2~ NPs could be absorbed into the body by different routes of exposure and distributed in various organs \[[@B27-nanomaterials-06-00225],[@B28-nanomaterials-06-00225]\]. Moreover, TiO~2~ NPs were found to be taken up by Peyer's Patch, which is present throughout the walls of the small intestine, after oral administration to rats \[[@B25-nanomaterials-06-00225]\]. It is worth noting that extremely low oral absorption efficiency of TiO~2~-NPs was demonstrated \[[@B25-nanomaterials-06-00225],[@B28-nanomaterials-06-00225]\]. However, relatively little information is currently available regarding the relationships between the biological interactions of TiO~2~ NPs with biomatrices, oral absorption, and potential toxicity; furthermore, conflicting results have often been reported.

In this study, we evaluated the biological behaviors of two kinds of TiO~2~ NPs, food grade (f-TiO~2~) and general grade (g-TiO~2~). Time-dependent physicochemical characterization of TiO~2~ NPs was performed in the presence of biomolecules. Albumin and glucose were chosen as representative model compounds as they are ubiquitous biomolecules and are often utilized as dispersing agents for various NPs \[[@B29-nanomaterials-06-00225],[@B30-nanomaterials-06-00225]\]. Moreover, their biokinetics were evaluated in terms of oral absorption, tissue distribution, and excretion after a single-dose oral administration to rats. In order to address the possible intestinal transport mechanism of NPs, an in vitro model of human intestinal follicle-associated epithelium (FAE) established on a 3-dimensional (3D) culture system was utilized.

2. Results {#sec2-nanomaterials-06-00225}
==========

2.1. Characterization {#sec2dot1-nanomaterials-06-00225}
---------------------

As shown in [Figure 1](#nanomaterials-06-00225-f001){ref-type="fig"}A,B, two kinds of TiO~2~ NPs were determined to have an anatase (JCPDS No. 21-1272) structure, exhibiting characteristic diffraction peaks of (101), (004), (200), (105), (211) and (204) reflection planes. As the X-ray diffraction (XRD) patterns of the two different TiO~2~ NPs were similar in terms of intensity and sharpness, both NPs were considered to have a similar degree of crystallite size. [Figure 1](#nanomaterials-06-00225-f001){ref-type="fig"}C,D displays scanning electron microscopic (SEM) images and the particle size distributions obtained from the SEM images. Both NPs had round, but irregular particle morphologies. Average primary particle sizes for 200 randomly selected particles in the SEM images were 117 ± 41 nm and 153 ± 49 nm for f-TiO~2~ and g-TiO~2~, respectively. In spite of the statistically similar primary particle size, g-TiO~2~ showed partial formation of agglomerates compared with f-TiO~2~. The Z-averages, based on the average hydrodynamic radii were 438 nm and 543 nm for f-TiO~2~ and g-TiO~2~, respectively; polydispersity indexes (PDI = \[(standard deviation)/(average diameter)\]^2^ obtained from hydrodynamic radius measurement), which reflect the homogeneity of a size distribution with a low value, were 0.398 and 0.479 for f-TiO~2~ and g-TiO~2~, respectively ([Figure S1](#app1-nanomaterials-06-00225){ref-type="app"}). These values imply that g-TiO~2~ tended to be more agglomerated than f-TiO~2~.

2.2. In Vitro and In Vivo Solubility {#sec2dot2-nanomaterials-06-00225}
------------------------------------

The in vitro solubility of TiO~2~ particles were evaluated in a simulated gastric fluid, because dissolution of NPs under acidic or physiological conditions can affect their bioavailability or biological fate, as in the case of ZnO and silver NPs \[[@B31-nanomaterials-06-00225],[@B32-nanomaterials-06-00225],[@B33-nanomaterials-06-00225]\]. The solubilities of f-TiO~2~ and g-TiO~2~ in simulated gastric fluid were 0.06% ± 0.03% and 0.05% ± 0.03%, respectively, which were fairly low and not significantly different from each other. In vivo solubilities in gastric fluid after a single-dose administration of 500 mg/kg via oral gavage to rats (the same dose used for the biokinetic study), were 0.05% ± 0.03% and 0.08% ± 0.05% for f-TiO~2~ and g-TiO~2~, respectively. The results reveal that both NPs, regardless of their primary particle size and degree of agglomeration, were dissolved less than 0.1% under acidic gastric condition.

2.3. Physicochemical Properties of TiO~2~ NPs in the Presence of Biomolecules {#sec2dot3-nanomaterials-06-00225}
-----------------------------------------------------------------------------

Time-dependent changes in colloidal properties, such as zeta potential, hydrodynamic radius, and PDI values of the TiO~2~ NPs in the presence of albumin or glucose are displayed in [Figure 2](#nanomaterials-06-00225-f002){ref-type="fig"}. f-TiO~2~ and g-TiO~2~ initially had average zeta potentials of −25 mV and −37 mV, respectively, but the initial negative zeta potentials shifted toward 0 upon adding 1% glucose. On the other hand, the values remained similar or shifted in the negative direction upon treatment with 1% albumin ([Figure 2](#nanomaterials-06-00225-f002){ref-type="fig"}A).

The hydrodynamic radii of the TiO~2~ NPs clearly showed different time-dependent changes according to the biomolecule type ([Figure 2](#nanomaterials-06-00225-f002){ref-type="fig"}B). In the presence of 1% glucose, the hydrodynamic diameters of both types of TiO~2~ NPs gradually increased to reach more than 1000 nm (from 438 nm to 1075 nm and from 543 nm to 1749 nm for f-TiO~2~ and g-TiO~2~, respectively). However, 1% albumin reduced the hydrodynamic radii of both types of TiO~2~ NPs significantly (from 438 nm to 366 nm and from 543 nm to 437 nm for f-TiO~2~ and g-TiO~2~, respectively). Changes in PDI values were in accordance with hydrodynamic radius changes ([Figure 2](#nanomaterials-06-00225-f002){ref-type="fig"}C). PDI values of both types of TiO~2~ NPs significantly reduced (from 0.385 to 0.190 and from 0.487 to 0.22 for f-TiO~2~ and g-TiO~2~, respectively) and were maintained below 0.25 in the presence of 1% albumin, showing fairly homogeneous distribution; however, 1% glucose gradually and dramatically increased PDI values upon incubation time, reaching 0.479 and 4.012 at 48 h for f-TiO~2~ and g-TiO~2~, respectively, suggesting the formation of large agglomerates. The degree of agglomeration was more remarked in g-TiO~2~ than in f-TiO~2~.

In order to evaluate the changes in crystalline phase and surface chemistry of the TiO~2~ NPs in the presence of biomolecules, XRD and X-ray photoelectron spectra (XPS) of the NPs before and after biomolecule treatment were compared. As shown in [Figure 3](#nanomaterials-06-00225-f003){ref-type="fig"}A,B, neither evolution of impurity phase nor significant changes in peak shape and intensity were found. These results reveal that both albumin and glucose did not affect dissolution of crystallite and phase transformation. According to quantitative analyses, less than 0.9% (*w*/*w*) of both albumin and glucose formed complexation with TiO~2~ NPs (data not shown), indicating only the surface of the NPs was covered with biomolecules. The surface interaction between NPs and biomolecules was further investigated with XPS ([Figure 3](#nanomaterials-06-00225-f003){ref-type="fig"}C,D). The original binding energy of \~459.3 eV (Ti p~3/2~) slightly increased for f-TiO~2~ in the presence of albumin, whereas the binding energy for g-TiO~2~ reduced in the presence of either albumin or glucose. This kind of binding energy change is thought to result from the coordination bond formation between surface Ti(IV) and glucose or albumin, as previously reported in other NPs \[[@B34-nanomaterials-06-00225],[@B35-nanomaterials-06-00225]\].

2.4. Intestinal Transport Mechanism {#sec2dot4-nanomaterials-06-00225}
-----------------------------------

The transport mechanism of two different types of TiO~2~ NPs across the intestinal epithelium was evaluated using an in vitro 3D cell culture system of a FAE model, by co-culturing human intestinal epithelial Caco-2 cells and human Raji B lymphocytes. This model represents specialized microfold (M) cells found in the FAE covering Peyer's patches, which play a role in the transport of a wide range of materials, including microorganisms, macromolecules, and particles, as well as the intestinal immune system \[[@B36-nanomaterials-06-00225],[@B37-nanomaterials-06-00225]\]. [Figure 4](#nanomaterials-06-00225-f004){ref-type="fig"}A shows that only f-TiO~2~ was found to be transported by M cells and its elevated transport amount was detected only at 37 °C, not at 4 °C, indicating an energy-dependent transport pathway. In the Caco-2 monoculture system without Raji B cells, which represents intestinal tight junctions, no increase in the transport of either f-TiO~2~ or g-TiO~2~ was observed (data not shown). The transcytosis mechanism of particle translocation by M cells was further assessed by ethylene glycol tetraacetic acid (EGTA) pre-treatment, which induces the opening of enterocyte tight junctions. The transport of both types of TiO~2~ NPs was not affected by the EGTA treatment ([Figure 4](#nanomaterials-06-00225-f004){ref-type="fig"}B).

2.5. Effects of Biomolecules on Oral Absorption {#sec2dot5-nanomaterials-06-00225}
-----------------------------------------------

Oral absorption of f-TiO~2~ was investigated in the presence of albumin or glucose, after a single-dose administration to rats, in order to determine the effects of interactions between the NPs and biomolecules on the oral absorption of NPs. [Figure 5](#nanomaterials-06-00225-f005){ref-type="fig"} demonstrates that the plasma concentration-time profiles of f-TiO~2~ remarkably increased in the presence of albumin or glucose, showing peak concentration at 0.5 h and 1 h for albumin and glucose, respectively. Interestingly, the oral absorption of NPs considerably and significantly decreased when they were dispersed in distilled water (D.W.), showing \~0.01% of absorption ([Table 1](#nanomaterials-06-00225-t001){ref-type="table"}). It is worth noting that the absorption rate and efficiency of f-TiO~2~ was significantly greater in albumin than in glucose.

2.6. Effect of TiO~2~ NP Type on Oral Absorption {#sec2dot6-nanomaterials-06-00225}
------------------------------------------------

The biokinetics of the two different types of TiO~2~ NPs were evaluated in the presence of 1% albumin because [Figure 5](#nanomaterials-06-00225-f005){ref-type="fig"} and [Table 1](#nanomaterials-06-00225-t001){ref-type="table"} demonstrated that the oral absorption efficiency of NPs dispersed in albumin was higher than in glucose. [Figure 6](#nanomaterials-06-00225-f006){ref-type="fig"} shows similar plasma concentration versus time curves for f-TiO~2~ and g-TiO~2~ with a maximum concentration at 0.5 h post-administration. However, when the biokinetic parameters were calculated, *C*~max~, area under the plasma concentration-time curve (AUC), and absorption values between f-TiO~2~ and g-TiO~2~ were significantly different, while both NPs had similar *T*~max~, *T*~1/2~, and mean residence time (MRT) values ([Table 2](#nanomaterials-06-00225-t002){ref-type="table"}). Interestingly, total oral absorptions were low at \<0.8% for both TiO~2~ NPs.

2.7. Tissue Distribution and Excretion Kinetics {#sec2dot7-nanomaterials-06-00225}
-----------------------------------------------

The biodistribution of the two different types of TiO~2~ NPs was assessed in possible target organs for accumulation \[[@B26-nanomaterials-06-00225],[@B38-nanomaterials-06-00225]\], that is, kidneys, liver, lungs, and spleen following a single oral administration (500 mg/kg, the same dose used for biokinetic study) to rats ([Figure 7](#nanomaterials-06-00225-f007){ref-type="fig"}). The f-TiO~2~ showed elevated Ti concentrations in the kidneys and lungs at 6 h and 1 day post-administration, respectively ([Figure 7](#nanomaterials-06-00225-f007){ref-type="fig"}A); similarly, Ti levels in the kidneys and lungs of rats administered g-TiO~2~ significantly increased at 6 h. ([Figure 7](#nanomaterials-06-00225-f007){ref-type="fig"}B). In both cases, elevated Ti levels decreased after 1 day post-administration in all organs analyzed.

The excretion kinetics of the two different types of TiO~2~ NPs following oral administration to rats (500 mg/kg) were evaluated by measuring total Ti concentrations in urine and feces ([Figure 8](#nanomaterials-06-00225-f008){ref-type="fig"}). Elevated Ti concentrations in urine were detected at 1--2 days post-administration and returned to normal levels thereafter ([Figure 8](#nanomaterials-06-00225-f008){ref-type="fig"}A). Relatively rapid excretion kinetics through the feces was observed for both types of TiO~2~ NPs, showing increased Ti levels only at 1 day post-administration ([Figure 8](#nanomaterials-06-00225-f008){ref-type="fig"}B). [Table 3](#nanomaterials-06-00225-t003){ref-type="table"} summarizes the total excretion values of the TiO~2~ NPs and showed that more than 85% of the NPs were directly excreted in feces, but only a small portion of the NPs was eliminated in urine. An effect of NP type on excretion kinetics was not found.

3. Discussion {#sec3-nanomaterials-06-00225}
=============

The biological responses of food and general grade TiO~2~ NPs were investigated based on their interactions with biomolecules, intestinal transport mechanism, and biokinetics. The physicochemical properties of f-TiO~2~ and g-TiO~2~ were found to be affected by the presence of glucose or albumin at 1% (*w*/*v*). Initial negative zeta potential values of TiO~2~ NPs turned more negative in the presence of albumin, while the zeta potential of NPs in glucose shifted toward 0 mV ([Figure 2](#nanomaterials-06-00225-f002){ref-type="fig"}A). Zeta potential is often related to the colloidal stability of NPs; absolute zeta potential values higher than 30 mV are known to increase colloidal stability due to the strong charge-charge repulsion among NPs \[[@B39-nanomaterials-06-00225]\]. In this regard, albumin increased the colloidal stability of the NPs, while glucose resulted in the agglomeration of TiO~2~ particles. The hydrodynamic radii and PDI values of the TiO~2~ NPs reduced in the presence of albumin, but significantly increased with glucose ([Figure 2](#nanomaterials-06-00225-f002){ref-type="fig"}B,C). A similar result was also reported by Šimundić et al., demonstrating the agglomeration tendency of TiO~2~ NPs in the presence of glucose \[[@B40-nanomaterials-06-00225]\]. These results suggest that albumin acts as a dispersant for TiO~2~ NPs. The dispersing effect of albumin was slightly higher for f-TiO~2~ than g-TiO~2~, and agglomeration by glucose was more significant for g-TiO~2~. This might be due to the slight difference in primary particle size and the formation of agglomerates in g-TiO~2~ ([Figure S1D](#app1-nanomaterials-06-00225){ref-type="app"}).

A stable suspension of TiO~2~ NPs in albumin, but agglomeration in glucose is likely to be highly related to the zeta potential change; however, agglomeration is not a simple consequence of a zeta potential value shift to zero. Agglomeration or stabilization of the TiO~2~ suspension could be induced by changes in surface chemistry, including surface interactions between biomolecules and TiO~2~ NPs. Glucose with negative charge centers at the hydroxyl groups cannot be easily adsorbed on the surfaces of negatively charged TiO~2~ NPs. Instead, they can be coordinated to the NP surfaces via interaction between surface Ti^4+^ and hydroxyls. The strength of coordination can be predicted by the hard-soft-acid-base theory, which explains the preferred combination of hard-hard or soft-soft species \[[@B41-nanomaterials-06-00225]\]. According to the theory, Ti^4+^ and hydroxyl in glucose are classified as hard acid and hard base, respectively, suggesting the possible bond formation between them. The XPS peak representing the binding energy for the metal cation shifted to lower energy when there was a coordination bond. In other words, coordinated electrons shield p~3/2~ electrons from nuclear charge \[[@B41-nanomaterials-06-00225]\], consequently resulting in binding energy reduction \[[@B42-nanomaterials-06-00225]\]. Both f-TiO~2~ and g-TiO~2~ showed a slight decrease in binding energy in the presence of albumin ([Figure 3](#nanomaterials-06-00225-f003){ref-type="fig"}C,D). This may be attributed to the adsorption of albumin on the TiO~2~ surface through electrostatic interaction. Significant binding energy reduction of g-TiO~2~ in the presence of glucose may be attributed to the surface coordinated glucose ([Figure 3](#nanomaterials-06-00225-f003){ref-type="fig"}D). Hence, it is likely that there was possible coordination bond between the TiO~2~ NPs and glucose, which made NP-glucose networks, finally leading to agglomeration. On the other hand, albumin is thought to attach to the NP surface through relatively weak van der Waals interactions, contributing to a relatively stable NP dispersion. The zeta potential change in [Figure 2](#nanomaterials-06-00225-f002){ref-type="fig"} could be explained by different surface interactions between albumin or glucose and TiO~2~-NPs.

When the human body is exposed to NPs by the oral route, the question as to whether NPs can be transported across the intestinal epithelium is fundamental in understanding their potential toxicity and absorption efficiency. Most studies have demonstrated little or low transportation of NPs in intestinal monocultures of Caco-2 cells \[[@B9-nanomaterials-06-00225],[@B23-nanomaterials-06-00225],[@B43-nanomaterials-06-00225]\]. However, this model represents enterocyte monolayers with a dense network of tight junctions, thereby preventing NP translocation. In the present study, we used a 3D co-culture system of Caco-2 cells and Raji B cells, a FAE model, to investigate NP transport by M cells. Indeed, M cells found in the FAE have a high capacity of transcytosis and can transport various materials, including NPs, soluble tracers, bacteria, and viruses \[[@B37-nanomaterials-06-00225]\]. Moreover, M cells are also known to be capable of energy-dependent endocytosis \[[@B16-nanomaterials-06-00225],[@B24-nanomaterials-06-00225],[@B36-nanomaterials-06-00225],[@B38-nanomaterials-06-00225]\]. In the present study, f-TiO~2~ was found to be transported by M cells in an energy-dependent manner, and exhibited significantly increased transport only when the temperature increased to 37 °C ([Figure 4](#nanomaterials-06-00225-f004){ref-type="fig"}A), which was not in the Caco-2 monolayer system (data not shown). On the other hand, the transport of f-TiO~2~ was not influenced by EGTA treatment, which suggests that NPs were efficiently transcytosed by M cells and a paracellular transport mechanism does not play a major role in NP uptake. No significantly increased transport of g-TiO~2~ may be related to their agglomerated fate in biological media ([Figure 2](#nanomaterials-06-00225-f002){ref-type="fig"}B,C). It seems that the slightly increased transport of f-TiO~2~ by M cells is related to its low oral absorption ([Table 2](#nanomaterials-06-00225-t002){ref-type="table"}). Meanwhile, no significantly increased transport of g-TiO~2~ may be attributed to its more agglomerated fate under physiological conditions than f-TiO~2~. Brun et al. demonstrated that TiO~2~ NPs accumulated and translocated into M cells by using a FAE model and TEM image analysis \[[@B26-nanomaterials-06-00225]\], and this is consistent with our results.

The effects of the presence of albumin or glucose on the biokinetics of TiO~2~ NPs were evaluated, which also aimed to identify an appropriate dispersant for in vivo administration. As shown in [Figure 5](#nanomaterials-06-00225-f005){ref-type="fig"} and [Table 1](#nanomaterials-06-00225-t001){ref-type="table"}, f-TiO~2~ dispersed in albumin or glucose entered the bloodstream more rapidly and highly as compared with the NP dispersion in D.W. Moreover, f-TiO~2~ in albumin had the highest absorption efficiency and rapid absorption rate than in glucose. This result implies that interactions between TiO~2~ and biomolecules could affect biokinetics and that these interactions are highly dependent on the physicochemical properties of the NPs and biomolecules. As a consequence, it is likely that albumin serves as a dispersant for TiO~2~, which is in good agreement with colloidal behaviors ([Figure 2](#nanomaterials-06-00225-f002){ref-type="fig"}).

Based on the above result, the biokinetics of f-TiO~2~ and g-TiO~2~ dispersed in albumin were carried out to determine the effects of NP type ([Figure 6](#nanomaterials-06-00225-f006){ref-type="fig"}). Oral absorption efficiency was statistically greater for f-TiO~2~ than g-TiO~2~ ([Table 2](#nanomaterials-06-00225-t002){ref-type="table"}), but their biokinetic profiles were similar, possibly because of the similar primary particle size ([Figure 1](#nanomaterials-06-00225-f001){ref-type="fig"}). Oral absorption of f-TiO~2~ was about 1.5 fold higher than g-TiO~2~, but the total absorption amounts of both NPs were less than 0.8% ([Table 2](#nanomaterials-06-00225-t002){ref-type="table"}), suggesting extremely low oral absorption efficiency. In one study, TiO~2~ NPs were found to have low absorption even after oral administration for 13 weeks, showing Ti levels at 0.4 to 0.5 µg/g in whole blood \[[@B26-nanomaterials-06-00225]\]. Therefore, it is likely that only a small portion of TiO~2~ NPs could be absorbed into the body. The significantly enhanced oral absorption of f-TiO~2~ compared to g-TiO~2~ can be explained by their efficient intestinal transport mechanism by M cells ([Figure 4](#nanomaterials-06-00225-f004){ref-type="fig"}), which can be also associated with relatively small hydrodynamic radii in aqueous solution ([Figure S1](#app1-nanomaterials-06-00225){ref-type="app"}). Meanwhile, the biological fate of both types of TiO~2~ NPs seems to be a particulate fate, based on their extremely low in vivo dissolution properties (\~0.05%). Particulate persistence of TiO~2~ NPs in gut epithelium or in Peyer's patches was also suggested by Janer et al. and Brun et al. \[[@B25-nanomaterials-06-00225],[@B26-nanomaterials-06-00225]\].

There was no significant difference in tissue distribution patterns ([Figure 7](#nanomaterials-06-00225-f007){ref-type="fig"}) or excretion kinetics ([Figure 8](#nanomaterials-06-00225-f008){ref-type="fig"}) depending on TiO~2~ type. Both types of TiO~2~ NPs accumulated only slightly in the kidneys and lungs at 6--24 h post-administration. Cho et al. reported that no significant increase in Ti levels occurred in sampled organs, including brain, liver, kidneys, and spleen, after 13-week repeated oral administration of TiO~2~ NPs dispersed in D.W. \[[@B28-nanomaterials-06-00225]\]. On the other hand, the elevated levels of all particles detected in the kidneys also indicate possible renal excretion, as evidenced in [Figure 8](#nanomaterials-06-00225-f008){ref-type="fig"}A. However, fecal excretion seems to play a major role in NP elimination, which is in good agreement with the previous report \[[@B14-nanomaterials-06-00225]\]. Taken together, most TiO~2~ NPs were not absorbed, and were directly eliminated through the feces.

4. Materials and Methods {#sec4-nanomaterials-06-00225}
========================

4.1. Materials and Characterization {#sec4dot1-nanomaterials-06-00225}
-----------------------------------

Food grade TiO~2~ NP (f-TiO~2~) and general grade TiO~2~ NP (g-TiO~2~) were purchased from Avantor Performance Materials Inc. (Center Valley, PA, USA) and Alfa Aesar Johnson Matthey Co. (Karlsruhe, Germany), respectively. Glucose and albumin were purchased from Sigma-Aldrich (St. Louis, MO, USA). Powder X-ray diffraction (XRD) patterns for NPs were measured using a X-ray diffractometer (D2phaser, Bruker AXS Inc., Madison, WI, USA) with Ni-filtered CuKα radiation. Particle size and morphology were examined by scanning electon microscopy (SEM; FEI QUANTA 250 FEG, Hillsboro, OR, USA). Zeta potential and hydrodynamic radii of the NPs in aqueous suspension were measured with an ELSZ-1000 instrument (Otsuka, Osaka, Japan).

4.2. Solubility and ICP-AES Analysis {#sec4dot2-nanomaterials-06-00225}
------------------------------------

For the in vitro solubility test, both NPs (5 mg/mL) were dispersed in simulated gastric fluid (0.2% NaCl, 0.32% pepsin, pH 1.5) and phosphate buffered saline (PBS, pH 7.4). After different incubation times at 37 °C, supernatants were collected by ultracentrifugation for 15 min. The in vivo solubility of the particles was analyzed after a single dose oral administration of 500 mg/kg to male rats as previously reported \[[@B44-nanomaterials-06-00225]\]. Briefly, stomachs were collected at 15 min post-administration after CO~2~ euthanasia, rinsed with saline, and the gastric fluids were extracted. After centrifugation of the gastric fluids at 12,000× *g* for 3 min at 4 °C, supernatants were obtained and passed through a syringe filter (pore size 0.45 µm; Advantech, Taipei, Taiwan) and pre-digested with ultrapure nitric acid (HNO~3~) and hydrogen peroxide (H~2~O~2~). For the quantitative analysis of Ti, the plasma samples were digested overnight in 10 mL of sulfuric acid (H~2~SO~4~) solution and the remaining solution was removed by heating. Aqua regia solution (HCl:HNO~3~ = 3:1, 5 mL) was then added. Finally, after adding HNO~3~ and H~2~O~2~ solution, the samples were heated at 180 °C until the solution was colorless and clear. The solutions were finally diluted to 5 mL with 2% HNO~3~ and total Ti contents were determined by inductively compled plasma-atomic emission spectroscopy (ICP-AES; JY2000 Ultrace, HORIBA Jobin Yvon, Stow, MA, USA).

4.3. Physicochemical Properties of TiO~2~ NPs in the Presence of Biomolecules {#sec4dot3-nanomaterials-06-00225}
-----------------------------------------------------------------------------

In order to evaluate the physicochemical properties of TiO~2~ NPs in different biological environments, TiO~2~ NPs were dispersed in 1% (*w*/*v*) solution of either albumin or glucose. The zeta potential change of the NPs after dispersion in each solution was recorded at 0, 2, 6, 24 and 48 h with light scattered electrophoresis (ELSZ-1000, Otsuka, Osaka, Japan). Hydrodynamic radii and polydispersity indexes (PDI) with respect to time were measured with dynamic light scattering (DLS) using an ELSZ-1000. The surface interaction between particles and biological molecules was investigated by measuring the binding energy of Ti p~3/2~ electrons, utilizing a X-ray photoelectron spectrophotometer (XPS; Thermo Fisher K-ALPHA, Waltham, MA, USA).

4.4. Intestinal Transport Mechanism {#sec4dot4-nanomaterials-06-00225}
-----------------------------------

An in vitro model of human intestinal FAE, representing M cells, was prepared according to the protocol developed by des Rieux et al. \[[@B45-nanomaterials-06-00225]\]. Human intestinal epithelial Caco-2 cells were purchased from the Korean Cell Line Bank (Seoul, Korea) and grown in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum, 1% non-essential amino acids, 1% [l]{.smallcaps}-glutamine, 100 units/mL penicillin, and 100 μg/mL streptomycin under the standard condition as described elsewhere \[[@B46-nanomaterials-06-00225]\]. Briefly, Transwell^®^ polycarbonate inserts (Corning Costar, New York, NY, USA) were coated with Matrigel^TM^ basement membrane matrix (Becton Dicknson, Bedford, MA, USA), prepared in pure DMEM, and were then placed at room temperature for 1 h. The supernatants were removed and the inserts were washed with DMEM. Caco-2 cells (5 × 10^5^ cells) were grown on the upper insert side and incubated for 14 days. Then, non-adherent human Burkitt's lymphoma Raji B cells (5 × 10^5^ cells, Korean Cell Line Bank) in the same medium were added to the basolateral insert compartment, and the co-cultures were maintained for 5 days. TiO~2~ NPs (250 μg/mL) were prepared in Hank's Balanced Salt Solution (HBSS, pH 7.4) buffer, and the apical medium of the cell monolayers was replaced by a particle suspension and incubated for 6 h. Basolateral solutions were then sampled and the concentrations of transported particles were estimated by measuring total Ti levels as described in the "Solubility and ICP-AES analysis''.

To investigate the role of the energy-dependent mechanism, the same experiments were performed at 4 °C and 37 °C, respectively. Transcellular particle transport by M cells was also evaluated as follows; inserts were incubated apically and basolaterally with 2.5 mM EGTA in HBSS (pH 7.4) twice for 15 min at 37 °C. Fresh EGTA was then placed basolaterally and the particle suspension was added to the apical side of the cell monolayers, and incubation was continued for 6 h. Then, the basolateral solution was sampled and anlayzed by ICP-AES. The cytotoxicity in the presence of particles or EGTA was assessed by measuring lactate dehydrogenase (LDH) release from the cytoplasm of damaged cells in the apical medium. The experiment was repeated three times on three separate days.

4.5. Animals {#sec4dot5-nanomaterials-06-00225}
------------

Five-week old male Sprague Dawley (SD) rats weighing 130--150 g were purchased from Nara Biotech Co., Ltd. (Seoul, Korea). Animals were housed in plastic laboratory animal cages in a ventilated room, which was maintained at 20 ± 2 °C/60% ± 10% relative humidity with a 12 h light/dark cycle. Water and commercial laboratory complete food for rats were available ad libitum. Animals were environmentally acclimated 7 days before treatment. All animal experiments were performed in compliance with the guidelines issued by the Animal and Ethics Review Committee of Seoul Women's University, Seoul, Korea.

4.6. Biokinetic Study {#sec4dot6-nanomaterials-06-00225}
---------------------

Six male rats per group were administered a single-dose of 500 mg/kg TiO~2~ NPs, dispersed for 48 h in D.W., 1% (*w/v*) glucose or 1% (*w/v*) albumin, via oral gavage, and the blood samples were collected via the tail vein at several time points (0, 0.5, 1, 2, 3, 4, 6 and 10 h) after oral administration. The highest dose at which acute toxicity was not observed was chosen based on the pre-toxicity test of each particle. Body weight changes, behaviors, and symptoms were recorded daily after treatment. An additional group of six rats received an equivalent volume of 1% (*w/v*) glucose or 1% (*w/v*) albumin solution and were used as controls. The blood samples were centrifuged at 3000 rpm for 15 min at 4 °C to obtain the plasma. The following biokinetic parameters were estimated using Kinetica software (version 4.4, Thermo Fisher Scientific, Waltham, MA, USA): Maximum concentration (*C*~max~), time to maximum concentration (*T*~max~), area under the plasma concentration-time curve (AUC), half-life (*T*~1/2~), and mean residence time (MRT).

For tissue distribution and excretion kinetic studies, 500 mg/kg TiO~2~ NPs in 5% albumin were orally administered. Tissue samples of the kidneys, liver, lungs, and spleen were collected at several time points (6 h, and 1, 2 and 3 days) following CO~2~ euthanasia. Urine and feces were also collected at 6 h, and 1, 2, and 3 days post-administration.

4.7. Statistical Analysis {#sec4dot7-nanomaterials-06-00225}
-------------------------

Results were expressed as means ± standard deviations. A one-way analysis of variance (ANOVA) with Tukey's Test was performed using SAS software, version 9.4 (SAS Institute Inc., Cary, NC, USA) to determine the significance of differences between the experimental groups. Statistical significance was accepted for *p* \< 0.05.

5. Conclusions {#sec5-nanomaterials-06-00225}
==============

In conclusion, interactions between TiO~2~ NPs and biomolecules can highly affect oral absorption of NPs, as demonstrated by the higher absorptions of f-TiO~2~ in albumin or glucose than in D.W., which is associated with their colloidal behaviors being affected by surface characteristics. Therefore, it seems that it is essential to consider the interactions between NPs and biomolecules for toxicity and efficacy studies. The oral absorption of TiO~2~ NPs is likely to be primarily associated with their efficient intestinal transport by M cells and can be affected by particle type. However, overall absorptions of f-TiO~2~ and g-TiO~2~ were less than 0.8%, and most of the particles were directly eliminated through the feces, suggesting low toxicity potential of TiO~2~ NPs.
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![Powder X-ray diffraction patterns of (**A**) food grade TiO~2~ (f-TiO~2~) and (**B**) general grade TiO~2~ (g-TiO~2~). Scanning electron microscopic images and corresponding size distribution histograms of (**C**) f-TiO~2~ and (**D**) g-TiO~2~.](nanomaterials-06-00225-g001){#nanomaterials-06-00225-f001}

![Time-dependent changes in colloidal properties. (**A**) Zeta potential; (**B**) hydrodynamic diameter; and (**C**) polydispersity index (PDI) values (PDI = \[(standard deviation)/(average diameter)\]^2^). Squares, f-TiO~2~; circles, g-TiO~2~; closed symbols, 1% glucose; open symbols, 1% albumin (□, f-TiO~2~ in 1% albumin; ■: f-TiO~2~ in 1% glucose; ○: g-TiO~2~ in 1% albumin; ●: g-TiO~2~ in 1% glucose). Data points at time 0 are the zeta potentials of each material in water without albumin or glucose.](nanomaterials-06-00225-g002){#nanomaterials-06-00225-f002}

![Powder X-ray diffraction patterns of (**A**) f-TiO~2~ and (**B**) g-TiO~2~ with or without biomolecules. X-ray photoelectron spectra of (**C**) f-TiO~2~ and (**D**) g-TiO~2~ with or without biomolecules. (a) TiO~2~ alone; (b) in 1% albumin; and (c) in 1% glucose.](nanomaterials-06-00225-g003){#nanomaterials-06-00225-f003}

![Intestinal transport mechanism of TiO~2~ NPs in vitro in a human follicle-associated epithelium (FAE) model. The transcytosis mechanism of particle transport was assessed by comparing transported amounts at 4 °C and 37 °C (**A**) and in the presence or absence of ethylene glycol tetraacetic acid (EGTA) at 37 °C (**B**). Mean values with different superscripts (A,B) for the same type of NP indicate significant differences at 4 °C and 37 °C (*p* \< 0.05). Mean values with different superscripts (a,b) in the same figure indicate significant differences among the control (cells in medium), f-TiO~2~-, and g-TiO~2~-treated groups (*p* \< 0.05).](nanomaterials-06-00225-g004){#nanomaterials-06-00225-f004}

![Effect of the presence of albumin or glucose on the plasma concentration-time profiles of f-TiO~2~ NPs after orally administering a single-dose (500 mg/kg) to rats. D.W., distilled water.](nanomaterials-06-00225-g005){#nanomaterials-06-00225-f005}

![Plasma concentration-time profiles of the two kinds of TiO~2~ NPs after orally administering a single-dose (500 mg/kg) to rats.](nanomaterials-06-00225-g006){#nanomaterials-06-00225-f006}

![Tissue distribution of (**A**) f-TiO~2~ and (**B**) g-TiO~2~ after orally administering a single-dose (500 mg/kg) to rats. Mean values with different superscripts (a,b) in the same organs indicate significant differences between control and particle-treated animals (*p* \< 0.05).](nanomaterials-06-00225-g007){#nanomaterials-06-00225-f007}

![Excretion kinetics of f-TiO~2~ and g-TiO~2~ via (**A**) urine and (**B**) feces after orally administering a single-dose (500 mg/kg) to rats. Mean values with different superscripts (a,b) at the same time points indicate significant differences between the control and particle-treated rats (*p* \< 0.05).](nanomaterials-06-00225-g008){#nanomaterials-06-00225-f008}
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###### 

Biokinetic parameters and oral absorption of food grade TiO~2~ (f-TiO~2~) particles in different biomolecules after a single oral administration to rats.

                       f-TiO~2~ (in D.W.)   f-TiO~2~ (in 1% Albumin)   f-TiO~2~ (in 1% Glucose)
  -------------------- -------------------- -------------------------- --------------------------
  ***C*~max~(mg/L)**   0.46 ± 0.09 ^a^      20.02 ± 1.35 ^c^           16.96 ± 1.110 ^b^
  ***T*~max~(h)**      0.5 ^a^              0.5 ^a^                    1 ^b^
  **AUC (h × mg/L)**   0.54 ± 0.03 ^a^      30.45 ± 8.34 ^c^           11.59 ± 1.42 ^b^
  ***T*~1/2~**         0.93 ± 0.18 ^a^      1.11 ± 0.09 ^a^            1.36 ± 0.11 ^b^
  **MRT (h)**          1.63 ± 0.30 ^a^      1.58 ± 0.48 ^a^            1.70 ± 0.07 ^a^
  **Absorption (%)**   0.01 ± 0.00 ^a^      0.78 ± 0.21 ^c^            0.30 ± 0.04 ^b^

Mean values with different superscripts (a--c) in the same column are significantly different (*p*\< 0.05). Absorption (%) was calculated based on AUC values. Abbreviation: D.W., distilled water; *C*~max~, maximum concentration; *T*~max~, time to maximum concentration; AUC, area under the plasma concentration-time curve; *T*~1/2~, half-life; MRT, mean residence time.
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###### 

Biokinetic parameters and oral absorption of different types of TiO~2~ particles after a single oral administration to rats.

                        f-TiO~2~           g-TiO~2~
  --------------------- ------------------ ------------------
  ***C*~max~ (mg/L)**   20.02 ± 1.35 ^a^   17.66 ± 0.98 ^b^
  ***T*~max~ (h)**      0.5 ^a^            0.5 ^a^
  **AUC (h × mg/L)**    30.45 ± 8.34 ^a^   20.28 ± 6.7 ^b^
  ***T*~1/2~**          1.11 ± 0.09 ^a^    1.29 ± 0.49 ^a^
  **MRT (h)**           1.58 ± 0.48 ^a^    1.80 ± 0.71 ^a^
  **Absorption (%)**    0.78 ± 0.21 ^a^    0.52 ± 0.17 ^b^

Mean values with different superscripts (a,b) in the same column are significantly different (*p* \< 0.05). Absorption (%) was calculated based on AUC values.
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###### 

Excretion profiles of the different types of TiO~2~ particles after a single oral administration to rats.

                                f-TiO~2~        g-TiO~2~
  ----------------------------- --------------- ---------------
  **Excretion via urine (%)**   0.31 ± 0.15     0.16 ± 0.02
  **Excretion via feces (%)**   85.20 ± 18.70   86.48 ± 16.96

[^1]: These authors contributed equally to this work.
